Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Cardura 2mg Tablet – PA0822/192/002
- Centrax 10mg Tablet – PA0822/010/001
- Flixotide 125mcg Evohaler – PA1077/044/014
- Fluzac 20mg Capsule – PA 0711/110/001
- Ipratropium Steri-Neb 250 micrograms/ml Nebuliser Solution - PA1986/083/001
- Ipramol Steri-Neb 0.5mg / 2.5mg per 2.5ml Nebuliser Solution - PA1986/082/001
- Levofloxacin 5mg/ml Solution for Infusion – PA1122/013/001
- Lotanos 100mg Film coated Tablet – PA0711/123/005
- Melcam 7.5mg Tablet – PA0711/060/001
- Melcam 15mg Tablet – PA0711/060/002
- Olmesartan 10mg Tablet – PA2315/113/001
- Olmesartan Rowex 10mg Tablet – PA0711/1255/001
- Rispone 6mg Film coated Tablet – PA0711/106/005
- Rivastigmine 6mg Capsule – EU/1/09/599/013-016
- Tavanic 5mg/ml Solution for Infusion – PA0540/077/001
- Tobi Podhaler 28mg Inhalation Powder, Capsule – EU/1/10/652/002
- Vancomycin 500mg Powder for Concentrate for Solution for Infusion & Oral Solution – PA1122/008/001
- Vancomycin 1000mg Powder for Concentrate for Solution for Infusion & Oral Solution – PA1122/008/002
- Verap 120mg Prolonged Release Tablet – PA0711/016/001
The following shortage has been resolved and supply has resumed to the Irish market:
- Donepezil Hydrochloride 10mg Tablet – PA0749/194/002
- Geodon 80mg Capsule – PA0822/214/004
- Olmesartan Medoxomil Clonmel 10mg Tablet – PA0126/273/001
- Zimovane 7.5mg Film Coated Tablet – PA2010/057/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.